FdaApplication
ANDA 209590
Identifiers
- fda_app_no: ANDA209590
Properties
| Property | Value |
|---|---|
| applicant_name | HETERO LABS LTD UNIT V |
| application_type | ANDA |
| approval_date | 2022-03-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | EQ 6MG BASE/ML | FOR SUSPENSION;ORAL |
1 product